
Venture capital · Early stage
4BIO Capital
London-based venture capital firm that invests solely in early-stage advanced therapies companies, with a team of research scientists, physicians and life science investors.
Investment activity
Round-by-round activity is part of PRO
Key signal this week
Is 4BIO Capital right for your round?
Key stats
Fund cycle Public record
No fund vehicles on the public registers we read.
Latest investments
BetaRounds 4BIO Capital joined, from press and the firm’s own posts.
1 round in the last 12 months
Round sizes, 4BIO Capital’s role and who invested alongside.
Where the money goes
Share of companies at first investment, from the rounds we track.
Investment team
Where to meet 4BIO Capital
Events where 4BIO Capital’s team spoke or showed up, from event programmes, press and the firm’s own posts.
Signals
Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.
Founders also look at
Frequently asked questions
4BIO Capital is based in London, United Kingdom.
Stages: Early stage. Sectors: Life sciences. From the firm’s own website.
Concentrates only on advanced therapies (cell, gene, RNA-based and targeted therapies plus the microbiome), giving investors pure exposure to a fast-growing area of medicine. Backs early-stage companies tackling serious unmet medical needs, supplying capital and expert guidance drawn from the team's own scientific research and investing experience, with the goal of making curative treatments available to every patient. From the firm’s own website.
Know before 4BIO Capital’s next round is announced.
PRO tracks 4BIO Capital’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.